Matt Miksic, an analyst from Barclays, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated price ...
Johnson & Johnson reported third-quarter earnings with adjusted EPS of $2.42, surpassing expectations. Sales rose 5.2% to $22.47B. J&J updated its 2024 adjusted EPS guidance, lowering it slightly to ...
When Keldon Johnson first encountered new teammate Chris Paul this summer at the San Antonio Spurs’ Victory Capital ...
Drug major Johnson & Johnson (JNJ), while reporting weak earnings but higher sales in its third quarter, on Tuesday trimmed its ...
A super PAC closely linked to House Speaker Mike Johnson (R-La.) is putting money into defending former House Freedom Caucus ...
At age 12, the Blue Jackets' future fifth overall pick was a scrawny forward who saw himself in a small, dynamic rookie for ...
In a groundbreaking move that's turning heads across the nation, LSU women's basketball sensation and up-and-coming rapper ...
The Dwayne Johnson-starring Christmas-themed comedy adventure film “Red One” is set for a theatrical release in mainland ...
Speaker Mike Johnson (R-La.) announced a $27.5 million fundraising haul for the third quarter of the year, a sum that is ...
Few things are as important for a team as having a solid and reliable shortstop and figuring out who that player will be for ...
During an endorsement interview with The Kansas City Star Editorial Board, Vanessa Riebli, Democratic candidate for Johnson ...
JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...